As patient care becomes more specialized, certain disease states have caught the attention of policymakers and drug manufacturers. This is due in part to the number of patients impacted by these conditions and the potential cost of care.
Get an insider's view on some of these specialty disease states from Ron Lanton, president of True North Political Solutions. He'll also provide an update on what your pharmacy can expect in the coming months.
This presentation will help attendees learn about:
MS, Alzheimer's, diabetes, and cancer
The latest policy considerations related to these diseases
New innovations within each disease state
How these diseases are being covered as well as specialty reimbursement concerns
MEDIWARE Information Systems Inc. published this content on 10 November 2017 and is solely responsible for the information contained herein.
Distributed by Public, unedited and unaltered, on 10 November 2017 23:18:02 UTC.